Trexquant Investment »

Aligos Therapeutics shares owned by Trexquant Investment

Quarter-by-quarter ownership of Aligos Therapeutics (ALGS) shares owned by Trexquant Investment from 13F filings

Historical chart of Trexquant Investment investment in Aligos Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aligos Therapeutics held by Trexquant Investment consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aligos Therapeutics by Trexquant Investment

Quarter filed Position value Share count Share price at filing
2026-06-30 $71k 12k 5.77
2025-03-31 $316k 38k 8.25
2024-12-31 $2.8M 69k 39.84

More positions owned by Trexquant Investment

NVIDIA Corporation Call Option (NVDA)
Amazon Call Option (AMZN)
Apple Call Option (AAPL)
Microsoft Corporation Call Option (MSFT)
Micron Technology Put Option (MU)
Tesla Motors Put Option (TSLA)
Alphabet Cap Stk Cl A Call Option (GOOGL)
JPMorgan Chase & Co. Call Option (JPM)
Alphabet Cap Stk Cl C Call Option (GOOG)
Meta Platforms Cl A Call Option (META)
Intuit Call Option (INTU)
Costco Wholesale Corporation Put Option (COST)
Palantir Technologies Cl A Put Option (PLTR)
Broadcom Call Option (AVGO)
Eli Lilly & Co. Call Option (LLY)

View all positions for Trexquant Investment

Top funds holding Aligos Therapeutics

Deep Track Capital
Alyeska Investment Group
Sio Capital Management
Marshall Wace
Woodline Partners
Vanguard Capital Management
Baker Bros. Advisors
Hillhouse Capital Advisors
D. E. Shaw & Co
UBS Group
Geode Capital Management
Jane Street
BlackRock
Vanguard Fiduciary Trust
Dimensional Fund Advisors

View all funds holding Aligos Therapeutics